Substituted benzamide with neuroleptic activity. Prepn: BE 620543; Thominet, US 3177252 (1962, 1965 to Soc. d'Etudes Sci. Ind. de l'Ile-de-France); R. Pakula et al., Arch. Pharm. 313, 297 (1980). Colorimetric determn in plasma and solubility: G. Pitel, T. Luce, Ann. Pharm. Fr. 23, 673 (1965). Dopamine D2 receptor antagonist (adenylate cyclase independent receptors): J. W. Kebabian, D. B. Calne, Nature 277, 93 (1979). Pharmacology: M. A. Smith, F. J. Salter, Drug Intell. Clin. Pharm. 14, 169 (1980). Pharmacokinetics: H. Vergin et al., Arzneim.-Forsch. 33, 458 (1983). Review of efficacy in psychiatric disorders: E. D. Peselow, M. Stanley, Adv. Biochem. Psychopharmacol. 35, 163-194 (1982); of pharmacology and clinical use: R. A. Harrington et al., Drugs 25, 451-494 (1983); ibid. Suppl. 1, 1-88. Comprehensive description: D. Pitré, R. Stradi, Anal. Profiles Drug Subs. 16, 327-361 (1987).
Antiemetic.
Antiemetic; Dopamine Receptor Antagonist